Clinical Trials Browser

Active not recruiting × Has announcements × belzutifan × Clear all

NCT04195750 2025-04-29

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Phase 3 Active not recruiting

755 enrolled 28 charts 1 FDA

Carcinoma, Renal Cell, Kidney Neoplasms

NCT03401788 2024-12-03

MK-6482-004

Phase 2 Active not recruiting

50 enrolled 1 FDA

von Hippel-Lindau Disease